UBX - Unity Biotech's chief medical officer Jamie Dananberg to exit company
2023-04-11 16:25:47 ET
- Unity Biotechnology ( NASDAQ: UBX ) said its chief medical officer Jamie Dananberg would leave the company, effective April 30.
- The company said Dananberg would receive a severance payment equal to nine months of his base salary and continued health care coverage for himself and his dependents.
- Dananberg is also eligible to enter into a consulting agreement with the company until December 31.
- ( UBX ) is down 2.7% .
For further details see:
Unity Biotech's chief medical officer Jamie Dananberg to exit company